Combined PAPPA-A and brachial flow-mediated dilatation to predict outcomes of patients with non-ST-elevation MI

Experimental and Clinical Cardiology

Volumn 20, Issue 6, 2014, Pages 3735-3754

  Mei, Wei Yi ^a   Liao, Li Zhen ^b   Hu, Xun ^a   Zhai, Yuan Sheng ^a   Du, Zhi Min ^a   Luo, Chu Fan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Endothelial function; acute coronary syndrome; Percutaneous coronary intervention; Pregnancy associated plasma protein A

Indexed keywords

PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BRACHIAL ARTERY; CORONARY ARTERY OBSTRUCTION; FEMALE; FLOW MEDIATED VASODILATION; FOLLOW UP; HEART DEATH; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; REVASCULARIZATION; RISK ASSESSMENT; VASODILATATION;

EID: 84903745769     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bayes-Genis A, Conover C A, Overgaard M T, et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med,2001;345:1022-9.
2. Cosin-Sales J, Christiansen M, Kaminski P, et al. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation,2004;109:1724-8. (Pubitemid 38500673)
3. Lund J, Qin Q P, Ilva T, et al. Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation,2003;108:1924-6. (Pubitemid 37296534)
4. Heeschen C, Dimmeler S, Hamm C W, Fichtlscherer S, Simoons M L, Zeiher A M. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol,2005;45:229-37. (Pubitemid 40094730)
5. Szmitko P E, Wang C H, Weisel R D, de Almeida J R, Anderson T J, Verma S. New markers of inflammation and endothelial cell activation: Part I. Circulation,2003;108:1917-23. (Pubitemid 37296533)
6. Chan N N, Colhoun H M, Vallance P. Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population. J Am Coll Cardiol,2001;38:1814-20. (Pubitemid 33116549)
7. Chan S H, Chen J H, Li Y H, Lin L J, Tsai L M. Increasing post-event plasma thrombomodulin level associates with worse outcome in survival of acute coronary syndrome. Int J Cardiol,2006;111:280-5.
8. Karatzis E N, Ikonomidis I, Vamvakou G D, et al. Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation. Am J Cardiol,2006;98:1424-8. (Pubitemid 44779467)
9. Mei W Y, Du ZM, Zhao Q, et al. Pregnancy-associated plasma protein predicts outcomes of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome. Heart Lung,2011;40:e78-83.
10. Bonaca M P, Scirica B M, Sabatine M S, et al. Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes. J Am Coll Cardiol,2012;60:332-8.
11. Oemrawsingh R M, Lenderink T, Akkerhuis K M, et al. Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome. Heart,2011;97:1061-6.
12. Consuegra-Sanchez L, Fredericks S, Kaski J C. Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk. Atherosclerosis,2009;203:346-52.
13. Li X P, Zhou S H, Tang J J, et al. Association between plasma pregnancy-associated plasma protein a and restenosis after percutaneous coronary angioplasty. Circ J,2008;72:729-33.
14. Anderson J L, Adams C D, Antman E M, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation,2007;116:e148-304.
15. Tertti R, Wittfooth S, Porela P, Airaksinen K E, Metsarinne K, Pettersson K. Intravenous administration of low molecular weight and unfractionated heparin elicits a rapid increase in serum pregnancy-associated plasma protein A. Clin Chem,2009;55:1214-7.
16. Overgaard M T, Haaning J, Boldt H B, et al. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem,2000;275:31128-33.
17. Corretti M C, Anderson T J, Benjamin E J, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol,2002;39:257-65. (Pubitemid 34084631)
18. Ciccone M M, Iacoviello M, Puzzovivo A, et al. Clinical correlates of endothelial function in chronic heart failure. Clin Res Cardiol,2011;100:515-21.
19. Gokce N, Holbrook M, Hunter L M, et al. Acute effects of vasoactive drug treatment on brachial artery reactivity. J Am Coll Cardiol,2002;40:761-5. (Pubitemid 34925624)
20. Gibson C M, Cannon C P, Murphy S A, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation,2000;101:125-30. (Pubitemid 30044249)
21. Lobbes M B, Kooi M E, Lutgens E, et al. Leukocyte counts, myeloperoxidase, and pregnancy-associated plasma protein a as biomarkers for cardiovascular disease: towards a multi-biomarker approach. Int J Vasc Med,2010;2010:726207.
22. Iversen K K, Teisner B, Winkel P, et al. Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial. Atherosclerosis,2011;214:203-8.
23. Elesber A A, Lerman A, Denktas A E, et al. Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergency department. Int J Cardiol,2007;117:365-9. (Pubitemid 46507629)
24. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation,2001;104:365-72. (Pubitemid 32666962)
25. Iversen K K, Teisner A S, Teisner B, et al. Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome. Clin Biochem,2009;42:828-34.
26. Wittfooth S, Tertti R, Lepantalo M, et al. Studies on the effects of heparin products on pregnancy-associated plasma protein A. Clin Chim Acta,2011;412:376-81.
27. Fichtlscherer S, Breuer S, Zeiher A M. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient. Circulation,2004;110:1926-32. (Pubitemid 39331903)
28. Huang P H, Chen J W, Lu T M, Yu-An D P, Lin S J. Combined use of endothelial function assessed by brachial ultrasound and high-sensitive C-reactive protein in predicting cardiovascular events. Clin Cardiol,2007;30:135-40.
29. Black M A, Cable N T, Thijssen D H, Green D J. Importance of measuring the time course of flow-mediated dilatation in humans. Hypertension,2008;51:203- 10. (Pubitemid 351159929)
30. Spiro J R, Digby J E, Ghimire G, et al. Brachial artery low-flow-mediated constriction is increased early after coronary intervention and reduces during recovery after acute coronary syndrome: characterization of a recently described index of vascular function. Eur Heart J,2011;32:856-66.
31. Kushner F G, Hand M, Smith S J, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol,2009;54:2205-41.
32. Chew D P, Bhatt D L, Robbins M A, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation,2001;104:992-7. (Pubitemid 32803874)
33. Consuegra-Sanchez L, Petrovic I, Cosin-Sales J, Holt D W, Christiansen M, Kaski J C. Prognostic value of circulating pregnancy-associated plasma protein-A (PAPP-A) and proform of eosinophil major basic protein (pro-MBP) levels in patients with chronic stable angina pectoris. Clin Chim Acta,2008;391:18-23.
34. Stulc T, Malbohan I, Malik J, Fialova L, Soukupova J, Ceska R. Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment. Am Heart J,2003;146:E21.
35. Fichtlscherer S, Rosenberger G, Walter D H, Breuer S, Dimmeler S, Zeiher A M. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation,2000;102:1000-6. (Pubitemid 30657516)